MARGARET BECKER: Open Payments
NPI 1093398620 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 26 payments from 15 companies in 2025. Trend: 2023 $866 · 2024 $529 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $86 |
| SHIELD THERAPEUTICS INC | 3 | $71 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| ABBVIE INC. | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $31 |
| Amgen Inc. | 1 | $28 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $24 |
| ViiV Healthcare Company | 1 | $21 |
Products named: Veozah, ACCRUFER, QULIPTA, SHINGRIX, MOUNJARO, KRYSTEXXA, NEFFY, APRETUDE.
Industry payments across GA — which companies pay providers there.
